SERPINB5

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA019025

Antibody HPA019132

Antibody HPA020136

Antibody CAB009570

Tissue

Antibody staining

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Most malignant cells were moderate or strongly stained. Strong staining was observed in squamous cell carcinomas and a majority of urothelial cancers. Most malignant gliomas and lymphomas were negative or weakly stained.Malignant cells displayed moderate to strong cytoplasmic immunoreactivity with additional nuclear staining. Squamous cell carcinomas generally showed strong cytoplasmic staining. Gliomas, lymphomas, breast and prostate cancers were weakly stained or negative.A majority of malignancies showed moderate to strong cytoplasmic staining. Malignant gliomas, carcinoids, testicular, renal and prostate cancers were generally negative. Squamous cell carcinomas of the skin, lung and urothelial cancers showed strong cytoplasmic and nuclear staining in several cases and in a few cases of pancreatic cancers. Remaining malignant cells showed weak to moderate cytoplasmic and nuclear positivity. Malignant gliomas and lymphomas were negative.

Literature conformity

Partly consistent with extensive gene/protein characterization dataPartly consistent with extensive gene/protein characterization dataPartly consistent with extensive gene/protein characterization dataPartly consistent with extensive gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected